We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Pebblebrook Hotel Trust
PEB
$2.16B
| $52.8M | 0.21% |
1,451,521
-42,206
| -3% | -$1.61M |
|
127
Emergent Biosolutions
EBS
$375M
| $52.5M | 0.21% |
797,408
-134,549
| -14% | -$7.85M |
|
|
DFS
128
DELISTED
Discover Financial Services
DFS
| $52.4M | 0.21% |
685,788
-215,861
| -24% | -$16.3M |
|
|
WBA
129
DELISTED
Walgreens Boots Alliance
WBA
| $52.4M | 0.21% |
718,779
-77,803
| -10% | -$5.28M |
|
130
CVS Health
CVS
$137B
| $52M | 0.21% |
660,137
+268,110
| +68% | +$19.2M |
|
131
Dollar Tree
DLTR
$23.1B
| $51.9M | 0.21% |
636,205
+8,405
| +1% | +$738K |
|
132
Dycom Industries
DY
$12.9B
| $51.9M | 0.21% |
613,071
-18,759
| -3% | -$1.62M |
|
133
Vanguard Real Estate ETF
VNQ
$39.9B
| $51.6M | 0.21% |
+639,999
| New | +$52.7M |
|
|
WMGI
134
DELISTED
Wright Medical Group Inc
WMGI
| $51.3M | 0.21% |
1,766,503
+529,647
| +43% | +$14.3M |
|
135
SLB Ltd
SLB
$77.8B
| $51.2M | 0.21% |
840,270
-13,110
| -2% | -$844K |
|
136
Emcor
EME
$33.1B
| $51.1M | 0.2% |
680,584
-17,670
| -3% | -$1.36M |
|
137
CACI
CACI
$10.8B
| $50.8M | 0.2% |
276,126
-85,279
| -24% | -$15.7M |
|
138
McCormick & Company Non-Voting
MKC
$13.4B
| $50.7M | 0.2% |
769,566
+64,660
| +9% | +$3.99M |
|
139
Nexstar Media Group
NXST
$5.6B
| $50.6M | 0.2% |
621,224
-17,935
| -3% | -$1.41M |
|
140
Bloomin' Brands
BLMN
$680M
| $50.3M | 0.2% |
2,541,036
-84,791
| -3% | -$1.66M |
|
141
Supernus Pharmaceuticals
SUPN
$2.68B
| $50M | 0.2% |
993,483
+340,677
| +52% | +$16.8M |
|
142
Etsy
ETSY
$7.65B
| $49.9M | 0.2% |
971,374
+398,632
| +70% | +$18.4M |
|
143
NextEra Energy
NEE
$187B
| $49.9M | 0.2% |
1,189,992
-14,820
| -1% | -$631K |
|
144
Western Alliance Bancorporation
WAL
$9.07B
| $49.7M | 0.2% |
873,290
-27,391
| -3% | -$1.58M |
|
145
Baxter International
BAX
$11.6B
| $49.5M | 0.2% |
642,234
+14,559
| +2% | +$1.08M |
|
|
AAN.A
146
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $49.3M | 0.2% |
905,504
-151,984
| -14% | -$8.28M |
|
147
Boyd Gaming
BYD
$6.47B
| $49.2M | 0.2% |
1,453,934
+146,686
| +11% | +$5.24M |
|
148
AMN Healthcare
AMN
$1.28B
| $49.2M | 0.2% |
899,260
-26,262
| -3% | -$1.5M |
|
|
DCH
149
Dauch Corp
DCH
$1.3B
| $48.9M | 0.2% |
2,804,892
-77,531
| -3% | -$1.33M |
|
150
Electronic Arts
EA
$52.4B
| $48.8M | 0.2% |
405,391
+128,895
| +47% | +$16.6M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.